Although p53 is often mutated in sebaceous carcinoma (Kiyosaki et al., 2010), many of these transcriptionally inactive mutations can inhibit AR activity (Nesslinger et al., 2003). Here, TP53 is linked to sebaceous adenocarcinoma.